Streptokinase (Cardiostrep 1.5iu Injection) is an enzyme, prescribed for heart attack, pulmonary embolism and deep vein thrombosis. It breaks up and dissolves blood clots that can block arteries. The ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Streptokinase (Eskinase 1.5MIU Injection) is an ...

Istanbul, Turkey - Administration of low-dose intracoronary streptokinase immediately after primary PCI improved myocardial reperfusion but not long-term left ventricular size or function in a new ...

Microvascular perfusion is often impaired after primary percutaneous coronary intervention (PCI). We proposed that in situ thrombosis might contribute to poor myocardial perfusion in this setting. To ...

Intrapleural fibrinolytic agents are used in the drainage of infected pleural-fluid collections. This use is based on small trials that did not have the statistical power to evaluate accurately ...

The study, published in the May 2005 issue of the European Heart Journal, tested streptokinase activity in 16 preparations of the drug produced by 11 manufacturers based in six countries: Korea, ...

In the UK, four thrombolytic agents are licensed and available to treat AMI. All act by promoting the activity of circulating plasminogen. There is a long history of use of one, streptokinase, whereas ...

BUERGER originally described thromboangiitis obliterans as primarily a thrombotic process occurring in arteries and veins 1; later he postulated that the thrombosis arose from an angiitis 2. Impressed ...